Daré Bioscience, Inc.

DARENASDAQHealthcare● Active

$1.85

$-0.03(-1.60%)

Market Cap$17615082

P/E Ratio—

52W High$9.19

52W Low$1.27

Avg Volume604K

Open$1.94

Beta1.02

Overview

Daré Bioscience, Inc. (DARE) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · DARE · as of Jun 8, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Daré Bioscience, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

DARE insider buying and selling by quarter

DARE insider selling · DARE insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

1.3M665K0

2022 Q2

2023 Q1

2023 Q2

2024 Q1

2024 Q2

2025 Q1

2025 Q3

2026 Q1

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Recent insider transactions

DARE executive sell shares · DARE board member insider trading · DARE insider trading SEC filing

Showing 1 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
Jul 19, 2017	JOHNSON SABRINA MARTUCCI CEO · Director	Award	962,062	$6.56	$6.31M⚡	962,062	Form 4

Date

Insider

Type

Value

Filing

Jul 19, 2017

JOHNSON SABRINA MARTUCCI

CEO · Director

Award

962,062

$6.31M⚡

Form 4

JOHNSON SABRINA MARTUCCI

CEO · Director

Award

Date

Jul 19

962,062

Price

$6.56

Value

$6.31M ⚡

View Form 4 on SEC.gov

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About DARE insider trading

DARE insider trades

Daré Bioscience, Inc. (DARE) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including DARE. Over the past 12 months, 0 insiders have filed transactions with the SEC. DARE insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Daré Bioscience, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

DARE insider trading · 5 questions

The insiders of Daré Bioscience, Inc. (DARE) include executives and directors such as DARE, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

DARE board member insider tradingwho are DARE insidersDARE insider rosterDaré Bioscience, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026